Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ.
Ethan MarkDavid GoldsmanPınar KeskinocakJoel SokolPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2019)
For all three organs, the majority of patients are predicted to have higher 5-year survival accepting an IRD organ offer compared with waiting for a non-IRD organ.